These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30575816)

  • 1. Tamoxifen mechanically deactivates hepatic stellate cells via the G protein-coupled estrogen receptor.
    Cortes E; Lachowski D; Rice A; Thorpe SD; Robinson B; Yeldag G; Lee DA; Ghemtio L; Rombouts K; Del Río Hernández AE
    Oncogene; 2019 Apr; 38(16):2910-2922. PubMed ID: 30575816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen mechanically reprograms the tumor microenvironment via HIF-1A and reduces cancer cell survival.
    Cortes E; Lachowski D; Robinson B; Sarper M; Teppo JS; Thorpe SD; Lieberthal TJ; Iwamoto K; Lee DA; Okada-Hatakeyama M; Varjosalo MT; Del Río Hernández AE
    EMBO Rep; 2019 Jan; 20(1):. PubMed ID: 30538116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPER is a mechanoregulator of pancreatic stellate cells and the tumor microenvironment.
    Cortes E; Sarper M; Robinson B; Lachowski D; Chronopoulos A; Thorpe SD; Lee DA; Del Río Hernández AE
    EMBO Rep; 2019 Jan; 20(1):. PubMed ID: 30538117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
    De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
    Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
    De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
    Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
    Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
    Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G protein-coupled estrogen receptor deficiency accelerates liver tumorigenesis by enhancing inflammation and fibrosis.
    Wei T; Chen W; Wen L; Zhang J; Zhang Q; Yang J; Liu H; Chen BW; Zhou Y; Feng X; Yang Q; Bai X; Liang T
    Cancer Lett; 2016 Nov; 382(2):195-202. PubMed ID: 27594673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen stabilizes hypoxia-inducible factor 1α through G protein-coupled estrogen receptor 1 in eutopic endometrium of endometriosis.
    Zhang L; Xiong W; Li N; Liu H; He H; Du Y; Zhang Z; Liu Y
    Fertil Steril; 2017 Feb; 107(2):439-447. PubMed ID: 27939762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPER-mediated proliferation and estradiol production in breast cancer-associated fibroblasts.
    Luo H; Yang G; Yu T; Luo S; Wu C; Sun Y; Liu M; Tu G
    Endocr Relat Cancer; 2014 Apr; 21(2):355-69. PubMed ID: 24481325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPER mediates activation of HIF1α/VEGF signaling by estrogens.
    De Francesco EM; Pellegrino M; Santolla MF; Lappano R; Ricchio E; Abonante S; Maggiolini M
    Cancer Res; 2014 Aug; 74(15):4053-64. PubMed ID: 24894716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
    J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper activates HIF-1α/GPER/VEGF signalling in cancer cells.
    Rigiracciolo DC; Scarpelli A; Lappano R; Pisano A; Santolla MF; De Marco P; Cirillo F; Cappello AR; Dolce V; Belfiore A; Maggiolini M; De Francesco EM
    Oncotarget; 2015 Oct; 6(33):34158-77. PubMed ID: 26415222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G protein-coupled estrogen receptor-1 agonist induces chemotherapeutic effect via ER stress signaling in gastric cancer.
    Lee SJ; Kim TW; Park GL; Hwang YS; Cho HJ; Kim JT; Lee HG
    BMB Rep; 2019 Nov; 52(11):647-652. PubMed ID: 31234952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic GPER translocation in cancer-associated fibroblasts mediates cAMP/PKA/CREB/glycolytic axis to confer tumor cells with multidrug resistance.
    Yu T; Yang G; Hou Y; Tang X; Wu C; Wu XA; Guo L; Zhu Q; Luo H; Du YE; Wen S; Xu L; Yin J; Tu G; Liu M
    Oncogene; 2017 Apr; 36(15):2131-2145. PubMed ID: 27721408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth.
    Catalano S; Giordano C; Panza S; Chemi F; Bonofiglio D; Lanzino M; Rizza P; Romeo F; Fuqua SA; Maggiolini M; Andò S; Barone I
    Breast Cancer Res Treat; 2014 Jul; 146(2):273-85. PubMed ID: 24928526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells.
    Vivacqua A; Romeo E; De Marco P; De Francesco EM; Abonante S; Maggiolini M
    Breast Cancer Res Treat; 2012 Jun; 133(3):1025-35. PubMed ID: 22147081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen induces toxicity, causes autophagy, and partially reverses dexamethasone resistance in Jurkat T cells.
    Torres-López L; Maycotte P; Liñán-Rico A; Liñán-Rico L; Donis-Maturano L; Delgado-Enciso I; Meza-Robles C; Vásquez-Jiménez C; Hernández-Cruz A; Dobrovinskaya O
    J Leukoc Biol; 2019 May; 105(5):983-998. PubMed ID: 30645008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1alpha (HIF-1alpha) in breast cancer cells and cardiomyocytes.
    Recchia AG; De Francesco EM; Vivacqua A; Sisci D; Panno ML; Andò S; Maggiolini M
    J Biol Chem; 2011 Mar; 286(12):10773-82. PubMed ID: 21266576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
    Li Y; Birnbaumer L; Teng CT
    Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphenol A induces proliferative effects on both breast cancer cells and vascular endothelial cells through a shared GPER-dependent pathway in hypoxia.
    Xu F; Wang X; Wu N; He S; Yi W; Xiang S; Zhang P; Xie X; Ying C
    Environ Pollut; 2017 Dec; 231(Pt 2):1609-1620. PubMed ID: 28964603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.